Renal Clinics Will Pay $4M To Settle Investors' Fraud Claims

By Dunstan Prial · January 31, 2018, 9:53 PM EST

Private equity-backed American Renal Associates Holdings Inc. on Wednesday agreed to pay $4 million to a class of shareholders who claimed in Massachusetts federal court that the dialysis clinic operator artificially...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum in Support of Motion

Case Information

Case Title

Esposito v. American Renal Associates Holdings, Inc. et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

September 02, 2016

Recent Articles By Dunstan

July 23, 2018
Theranos Settles Indirect Investors' Fraud Suit
June 01, 2018
Theranos Indirect Investors Denied Class Cert. For Fraud Suit
May 16, 2018
3 Ex-Constellation Execs Charged With $300M Stock Fraud
January 24, 2018
Express Scripts Escapes Shareholder Class Action
November 20, 2017
SEC Judge Refuses To Bar Shkreli Without Tie To Adviser